VanEck Pharmaceutical ETF (NASDAQ:PPH) Increases Dividend to $0.84 Per Share

VanEck Pharmaceutical ETF (NASDAQ:PPH) announced a quarterly dividend on Tuesday, March 31st, NASDAQ Dividends reports. Investors of record on Wednesday, April 1st will be paid a dividend of 0.8441 per share on Tuesday, April 7th. This represents a c) dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend is Wednesday, April 1st. This is a 171.8% increase from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

VanEck Pharmaceutical ETF Price Performance

PPH traded up $0.75 during trading on Wednesday, hitting $104.63. The company had a trading volume of 338,945 shares, compared to its average volume of 449,670. VanEck Pharmaceutical ETF has a 1-year low of $77.67 and a 1-year high of $112.58. The company has a market cap of $1.16 billion, a PE ratio of 20.21 and a beta of 0.54. The business has a 50-day moving average of $106.97 and a 200-day moving average of $100.77.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.